The Risk of Candidiasis During Treatment with Bimekizumab for the Management of Plaque Psoriasis: A 16-Week Multicenter Real-World Experience - IL PSO (Italian Landscape Psoriasis)

Clin Exp Dermatol. 2024 Oct 7:llae400. doi: 10.1093/ced/llae400. Online ahead of print.
No abstract available

Keywords: adverse events; bimekizumab; candidiasis; psoriasis.